Your browser doesn't support javascript.
loading
Leaving No One Behind: Interventions and Outcomes of the COVID-19 Vaccine Maximising Uptake Programme.
Berrou, Ilhem; Hamilton, Kathryn; Cook, Clare; Armour, Clare; Hughes, Sian; Hancock, Jude; Quigg, Sally; Hajinur, Huda; Srivastava, Seema; Kenward, Charlie; Ali, Amjid; Hobbs, Laura; Milani, Elena; Walsh, Nicola.
Afiliação
  • Berrou I; Glenside Campus, School of Health and Social Wellbeing, University of the West of England, Bristol BS16 1DD, UK.
  • Hamilton K; South West England Public Health Training Scheme, First Floor, Park House, 1200 Bristol Parkway North, Newbrick Road, Bristol BS34 8YU, UK.
  • Cook C; South West England Public Health Training Scheme, First Floor, Park House, 1200 Bristol Parkway North, Newbrick Road, Bristol BS34 8YU, UK.
  • Armour C; South West England Public Health Training Scheme, First Floor, Park House, 1200 Bristol Parkway North, Newbrick Road, Bristol BS34 8YU, UK.
  • Hughes S; National Health Service (NHS) Bristol, North Somerset and South Gloucestershire CCG, 360 Bristol, Marlborough Street, Bristol BS1 3NX, UK.
  • Hancock J; National Health Service (NHS) Bristol, North Somerset and South Gloucestershire CCG, 360 Bristol, Marlborough Street, Bristol BS1 3NX, UK.
  • Quigg S; National Health Service (NHS) Bristol, North Somerset and South Gloucestershire CCG, 360 Bristol, Marlborough Street, Bristol BS1 3NX, UK.
  • Hajinur H; Caafi Health, Unit 18, The Coach House, 2 Upper York Street, St Paul's, Bristol BS2 8QN, UK.
  • Srivastava S; South West England Public Health Training Scheme, First Floor, Park House, 1200 Bristol Parkway North, Newbrick Road, Bristol BS34 8YU, UK.
  • Kenward C; National Health Service (NHS) Bristol, North Somerset and South Gloucestershire CCG, 360 Bristol, Marlborough Street, Bristol BS1 3NX, UK.
  • Ali A; NHS Blood and Transplant 500, North Bristol Park, Filton, Bristol BS34 7QH, UK.
  • Hobbs L; Department of Applied Sciences, Frenchay Campus, University of the West of England, Bristol BS16 1QY, UK.
  • Milani E; Department of Applied Sciences, Frenchay Campus, University of the West of England, Bristol BS16 1QY, UK.
  • Walsh N; Glenside Campus, School of Health and Social Wellbeing, University of the West of England, Bristol BS16 1DD, UK.
Vaccines (Basel) ; 10(6)2022 May 25.
Article em En | MEDLINE | ID: mdl-35746447
ABSTRACT
The devastating impact of COVID-19 on individuals and communities has accelerated the development of vaccines and the deployment of ambitious vaccination programmes to reduce the risks of infection, infection transmission and symptom severity. However, many people delay or refuse to get vaccinated against COVID-19, for many complex reasons. Vaccination programmes that are tailored to address individual and communities' COVID-19 concerns can improve vaccine uptake rates and help achieve the required herd-immunity threshold. The Maximising Uptake Programme has led to the vaccination of 7979 people from February-August 2021 in the South West of England, UK, who are at high risk of severe illness from COVID-19 and/or may not access the COVID-19 vaccines through mass vaccination centres and general practices. These include people experiencing homelessness; non-English-speaking people; people from minority ethnic groups; refugees and asylum seekers; Gypsy, Roma, Travelers and boat people; and those who are less able to access vaccination centres, such as people with learning difficulties, serious mental illness, drug and alcohol dependence, people with physical and sensory impairment, and people with dementia. Outreach work coupled with a targeted communication and engagement campaign, co-designed with community leaders and influencers, have led to significant engagement and COVID-19 vaccine uptake among the target populations.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 Base de dados: MEDLINE Aspecto: Implementation_research Idioma: En Revista: Vaccines (Basel) Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 Base de dados: MEDLINE Aspecto: Implementation_research Idioma: En Revista: Vaccines (Basel) Ano de publicação: 2022 Tipo de documento: Article